info@seagull-health.com
SeagullHealth
语言:
search

How should I use this medicine?

ORENCIA dosage varies based on the patient’s condition, weight, and whether intravenous or subcutaneous administration is used.

Dosage and Administration of ORENCIA

For intravenous administration in RA and PsA, ORENCIA is given at 0, 2, and 4 weeks, then every 4 weeks thereafter. The dose is based on body weight: patients under 60 kg receive 500 mg, those between 60-100 kg get 750 mg, and those above 100 kg receive 1,000 mg. For subcutaneous use, adults should administer 125 mg weekly after an optional IV loading dose. Pediatric patients with pJIA or PsA are given 50-125 mg weekly based on their weight. In aGVHD prophylaxis, dosing varies by age and weight, with doses ranging from 10 mg/kg to 15 mg/kg.

ORENCIA(Abatacept)
ORENCIA(Abatacept)
ORENCIA is indicated for the treatment of adults with moderately to severely...
WeChat Scan
Free Inquiry
Related articles
共 0 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved